Case Report: Long-Term Follow-Up of Visceral Leishmaniasis and HIV Coinfected Patients Without Relapse: Lymphoproliferative Response After Stimulation with Soluble <i>Leishmania</i> Antigen

Highly active antiretroviral therapy (HAART) has reduced the incidence of VL/HIV dramatically. However, HAART only partially prevents relapses, with one-year relapse rates ranging from 30 to 60%. Consequently, secondary prophylaxis is recommended for patients with <200 CD4+ cells/μL. In clinical pra...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Begoña Monge-Maillo, Daniel Roger-Zapata, Fernando Dronda, Eugenia Carrillo, Javier Moreno, María Dolores Corbacho-Loarte, Diego Gayoso Cantero, Oihane Martín, Sandra Chamorro-Tojeiro, Jose A. Perez-Molina, Francesca Norman, Marta González-Sanz, Rogelio López-Vélez
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-03-01
Serie:	Microorganisms
Soggetti:	visceral leishmaniasis HIV lymphoproliferative response relapse secondary prevention recurrence
Accesso online:	https://www.mdpi.com/2076-2607/13/3/686
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!